Inflexion to buy majority stake in dss from Gyrus Capital

• Inflexion is making the investment from its Buyout Fund VI which closed on £2.5bn in March 2022
• dss and Gyrus’s management will retain a minority stake in the firm
• Inflexion, based in London, is a mid-market private equity firm

Inflexion Equity Partners has entered into an agreement to buy a majority stake in dss from Gyrus Capital.

dss is a provider of operations management consulting services based in Versoix, Geneva. The firm focuses on high-risk industries where safety, operations and culture transformation are mission critical.

The transaction is subject to relevant regulatory approvals.

Inflexion is making the investment from its Buyout Fund VI which closed on £2.5 billion ($3.02 billion; €2.89 billion) in March 2022.

“The commitment of the dss management to building the business and establishing it as a successful standalone entity makes them well placed to grow further as we work together to enhance their offering both organically and through global M&A,” said Flor Kassai, head of the Buyout Fund at Inflexion.

dss will partner with Inflexion to enhance its offering both organically and through M&A in a fragmented market, according to a release.

Gyrus and the management of dss will maintain a significant minority stake in the firm.

“We are very proud to have partnered with the dss management team in their carve out from DuPont and the first stage of their growth path as an independent firm,” said Guy Semmens, managing partner at Gyrus. “We are delighted to be able to remain investors and continue that partnership in its next phase.”

Gyrus is an investment firm dedicated to transformational  investments in the healthcare and sustainability sectors. The firm, based in Geneva, Switzerland, focuses on complex transactions, particularly corporate carve outs, in the €50 million to €500 million range.

Inflexion, based in London, is a mid-market private equity firm. The funds advised by Inflexion have funds under management of  around £8 billion. It invests £10 million to £400 million of equity in each deal and has offices in Manchester and Amsterdam.